BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |
| Summit X, LLC | 162,368 | $493,624 | 0.16% |
| Virtus ETF Advisers LLC | 78,827 | $239,634 | 0.15% |
| Woodline Partners LP | 2,728,737 | $8,295,360 | 0.10% |
| CAXTON ASSOCIATES LP | 152,389 | $463,263 | 0.06% |
| Baker Brothers Advisors | 2,499,715 | $7,599,134 | 0.04% |
| PROFUND ADVISORS LLC | 216,366 | $657,753 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,841,584 | $5,598,415 | 0.03% |
| Rafferty Asset Management, LLC | 1,491,411 | $4,533,889 | 0.03% |
| HOLDERNESS INVESTMENTS CO | 20,049 | $60,949 | 0.02% |
| CHANNEL WEALTH LLC | 12,500 | $38,000 | 0.02% |
External links
This page lists BLUEBIRD BIO INC's shareholders in Q3 2023. To view BLUEBIRD BIO INC's shareholder history, click here.